Fedha

Hisa unazofuatilia
Kwa nini STAR imepungua kwa 3.46%?
Fahamu zaidi
STAR:NSE
Strides Pharma Science Ltd
₹ 1,000.10
-3.46%
(-35.80) Siku 1
9 Nov, 15:30:00 GMT +5:30  ·   INR
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya STAR...
Fungua
₹ 1,033.10
Juu
₹ 1,039.90
Chini
₹ 1,000.00
Mtaji wa soko
92.40B
Wastani wa kiasi cha mauzo
elfu 348.62
Kiasi cha mauzo ya hisa
elfu 198.74
Gawio
0.50%
Mgawo wa faida wa kila robo mwaka
₹ 1.25
Tarehe ya kutojumuisha gawio
31 Jul 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
14.95
Juu kwa wiki 52
₹ 1,260.90
Chini kwa wiki 52
₹ 768.65
EPS
₹ 66.90
Hisa za wawekezaji
89.55M
Idadi ya wafanyakazi
elfu 4
Fungua
₹ 1,033.10
Juu
₹ 1,039.90
Chini
₹ 1,000.00
Mtaji wa soko
92.40B
Wastani wa kiasi cha mauzo
elfu 348.62
Kiasi cha mauzo ya hisa
elfu 198.74
Gawio
0.50%
Mgawo wa faida wa kila robo mwaka
₹ 1.25
Tarehe ya kutojumuisha gawio
31 Jul 2026
Uwiano wa bei ya hisa na mapato kwa kila hisa
14.95
Juu kwa wiki 52
₹ 1,260.90
Chini kwa wiki 52
₹ 768.65
EPS
₹ 66.90
Hisa za wawekezaji
89.55M
Idadi ya wafanyakazi
elfu 4
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. The company partners with generic companies to supply retail and hospital generics in injectable products and softgels. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India. Strides Arcolab changed name to Strides Shasun Ltd after an amalgamation of Shasun Pharmaceuticals with Strides Arcolab. In September 2014, the Board of Directors of both the companies had approved a scheme of amalgamation between the two companies. Arun Kumar is the founder and chairman, and has been on the board as managing director since its inception. Wikipedia
Kuhusu Strides Pharma Science Ltd
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 3.54
Lilianzishwa1990
Makao makuuBangalore, Karnataka, India
SektaHealth Care
Sekta-
Ripoti ya mwisho
30 Okt 2026
Kipindi cha Kifedha
Robo2 2027
- / -
Mapato dhidi ya makadirio (INR)
14.30B / 14.15B
Mkutano pepe wa kujadili mapato ya robo ya Robo ya 2 ya mwaka wa fedha wa 2027
Inasubiri mkutano pepe wa kujadili mapato
Kwa muhtasari
Maarifa kutoka kwenye ripoti na habari za hivi punde
Ripoti za awaliThamani zote katika INR
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika INR
Des 2025
Mac 2026
Jun 2026
Sep 2026
Mapato
11.95B
13.23B
12.65B
14.30B
Gharama ya bidhaa zilizouzwa
4.63B
7.19B
4.95B
6.29B
Gharama ya mapato
4.63B
7.19B
4.95B
6.29B
Gharama za utafiti na maendeleo
-
-
-
-
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
2.30B
3.45B
2.43B
2.38B
Gharama ya uendeshaji
5.46B
4.91B
5.97B
6.07B
Jumla ya gharama za uendeshaji
10.09B
12.10B
10.92B
12.36B
Mapato ya uendeshaji
1.85B
1.13B
1.73B
1.94B
Mapato mengine yasiyo ya uendeshaji
1.07B
-1.66B
48.90M
40.83M
EBT ikijumuisha vipengee visivyo vya kawaida
2.45B
1.48B
2.00B
1.50B
EBT bila kujumuisha vipengee visivyo vya kawaida
2.49B
502.07M
1.36B
1.52B
Gharama ya kodi ya mapato
373.53M
187.70M
341.23M
163.18M
Kiwango cha kodi kinachotumika
15.22%
12.68%
17.09%
10.85%
Gharama nyingine za uendeshaji
2.66B
928.53M
2.97B
3.11B
Mapato halisi
2.02B
1.27B
1.57B
1.31B
Kiwango cha faida halisi
16.92%
9.59%
12.40%
9.15%
Mapato kwa kila hisa
-
-
-
-
Mapato ya riba na uwekezaji
-
404.82M
-
-
Gharama ya riba
-433.79M
-130.82M
-405.61M
-465.41M
Jumla ya gharama halisi za riba
-433.79M
274.00M
-405.61M
-465.41M
Gharama za kushuka kwa thamani na za kulipa deni
506.23M
532.49M
563.99M
572.15M
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
2.25B
1.55B
2.15B
2.51B
Faida au hasara kutokana na uuzaji wa vipengee
-
-
-
-
Matukio yajayo
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
Programu za Google